Remicade (infliximab) Drug Market Report

Global and China Remicade (infliximab) Drug Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 19, 2022
  • PAGES：148
  • REPORT CODE：GMM1477462
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Remicade (infliximab) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Epirus Biopharmaceuticals

    • Hospira

    • Celltrion Healthcare

    • Samsung Bioepsis

    • Janssen

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Brands Drugs

    • Generic Drugs

    Application:

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Remicade (infliximab) Drug Industry Overview

      • 1.1.1 Remicade (infliximab) Drug Market Scope and Market Segments

      • 1.1.2 Remicade (infliximab) Drug Industry Characteristics

      • 1.1.3 Global and China Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Remicade (infliximab) Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Remicade (infliximab) Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Brands Drugs

      • 1.2.2 Generic Drugs

    • 1.3 Global Remicade (infliximab) Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Generic Drugs

      • 1.3.2 Generic Drugs

      • 1.3.3 Generic Drugs

      • 1.3.4 Generic Drugs

      • 1.3.5 Generic Drugs

      • 1.3.6 Generic Drugs

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Remicade (infliximab) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Remicade (infliximab) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Remicade (infliximab) Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Remicade (infliximab) Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Remicade (infliximab) Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Remicade (infliximab) Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Remicade (infliximab) Drug Industry PEST Analysis

    • 2.3 Remicade (infliximab) Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Remicade (infliximab) Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Remicade (infliximab) Drug Industry

    Chapter 3 Global and China Remicade (infliximab) Drug Market, by Manufacturer

    • 3.1 Global and China Remicade (infliximab) Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Remicade (infliximab) Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Remicade (infliximab) Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Remicade (infliximab) Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Remicade (infliximab) Drug Market Top 3 Players

    Chapter 4 Global and China Remicade (infliximab) Drug Market, by Type (2017-2028)

    • 4.1 Remicade (infliximab) Drug Market Trend, by Type

    • 4.2 Global Remicade (infliximab) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Remicade (infliximab) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Remicade (infliximab) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Remicade (infliximab) Drug Price Trend, by Type (2017-2028)

    • 4.3 China Remicade (infliximab) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Remicade (infliximab) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Remicade (infliximab) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Remicade (infliximab) Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Remicade (infliximab) Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Remicade (infliximab) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Remicade (infliximab) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Remicade (infliximab) Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Remicade (infliximab) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Remicade (infliximab) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Remicade (infliximab) Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Remicade (infliximab) Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Remicade (infliximab) Drug Market Analysis

    • 7.1 North America Remicade (infliximab) Drug Market, by Type

    • 7.2 North America Remicade (infliximab) Drug Market, by Application

    • 7.3 North America Remicade (infliximab) Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Remicade (infliximab) Drug Market Analysis

    • 8.1 Europe Remicade (infliximab) Drug Market, by Type

    • 8.2 Europe Remicade (infliximab) Drug Market, by Application

    • 8.3 Europe Remicade (infliximab) Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Remicade (infliximab) Drug Market Analysis

    • 9.1 APAC Remicade (infliximab) Drug Market, by Type

    • 9.2 APAC Remicade (infliximab) Drug Market, by Application

    • 9.3 APAC Remicade (infliximab) Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Remicade (infliximab) Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Remicade (infliximab) Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Remicade (infliximab) Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Remicade (infliximab) Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Remicade (infliximab) Drug Company Profiles

      • 11.1 Epirus Biopharmaceuticals

        • 11.1.1 Epirus Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Profiles, Application and Specification

        • 11.1.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Hospira

        • 11.2.1 Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Hospira Remicade (infliximab) Drug Product Profiles, Application and Specification

        • 11.2.3 Hospira Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Celltrion Healthcare

        • 11.3.1 Celltrion Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Celltrion Healthcare Remicade (infliximab) Drug Product Profiles, Application and Specification

        • 11.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Samsung Bioepsis

        • 11.4.1 Samsung Bioepsis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Samsung Bioepsis Remicade (infliximab) Drug Product Profiles, Application and Specification

        • 11.4.3 Samsung Bioepsis Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Janssen

        • 11.5.1 Janssen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Janssen Remicade (infliximab) Drug Product Profiles, Application and Specification

        • 11.5.3 Janssen Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Remicade (infliximab) Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Remicade (infliximab) Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Remicade (infliximab) Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Remicade (infliximab) Drug Production Value and Growth Rate (2017-2028)

    • Figure China Remicade (infliximab) Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Brands Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure Global Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs (2017-2028)

    • Figure North America Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Remicade (infliximab) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Remicade (infliximab) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Remicade (infliximab) Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Remicade (infliximab) Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Remicade (infliximab) Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Remicade (infliximab) Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Remicade (infliximab) Drug Market Share, by Manufacturer in 2022

    • Table Global Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Value, by Type (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Remicade (infliximab) Drug Price Trend, by Type (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Value, by Type (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Value Share, by Type (2017-2028)

    • Figure China Remicade (infliximab) Drug Price Trend, by Type (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Value, by Application (2017-2028)

    • Table Global Remicade (infliximab) Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Remicade (infliximab) Drug Sales Value Share, by Application (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Value, by Application (2017-2028)

    • Table China Remicade (infliximab) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Remicade (infliximab) Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table North America Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table North America Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table Europe Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table Europe Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table APAC Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table APAC Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Remicade (infliximab) Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Remicade (infliximab) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Remicade (infliximab) Drug Sales Value and Growth Rate (2017-2028)

    • Table Epirus Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Epirus Biopharmaceuticals Product Profiles, Application and Specification

    • Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hospira Product Profiles, Application and Specification

    • Table Hospira Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celltrion Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celltrion Healthcare Product Profiles, Application and Specification

    • Table Celltrion Healthcare Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Samsung Bioepsis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Samsung Bioepsis Product Profiles, Application and Specification

    • Table Samsung Bioepsis Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Janssen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Product Profiles, Application and Specification

    • Table Janssen Remicade (infliximab) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US